Anastasia Tikhonova, PhD, was named a 2023 NextGen Star by the AACR. The researchers conducted the study because tattoo inks can contain carcinogens and may migrate to the lymphatic system. Anastasia Tikhonova, PhD, talks about her research on the immune microenvironment in T-cell ALL. BV-AVEPC showed “consistent efficacy” in pediatric patients across age groups “despite lower exposure." Marina Konopleva, MD, PhD, tells us about the sessions that drew her eye at the 2023 AACR Annual Meeting. Planning for a phase III trial of the combination is underway. Jan Bewersdorf, MD, discusses a current ongoing phase I study investigating the combination of ruxolitinib and abemaciclib. Orelabrutinib plus tafasitamab and lenalidomide showed “synergistic effects” in preclinical models of B-cell ... Dr. Tauro speaks about her presentation on novel strategies to overcome chemotherapy resistance in MM at AACR 2023. The classifier is a “potential tumor-agnostic, plasma-based cell-free DNA minimal residual disease” test. Marina Konopleva, MD, PhD, speaks about her presentation at the AACR Annual Meeting 2023 in this video. Deletion of RHOA is “strongly associated with poor response” to a certain CAR-T therapy in patients with DLBCL. The design of the bispecific antibody aims to overcome challenges with cytokine release syndrome. Courtney DiNardo, MD, MSCE, discusses a first-in-human phase I study investigating LY3410738. Courtney Jones, PhD, discusses her AACR session on metabolism on AML stem cells. These five-year data from L-MIND provide further validation of the durability of the responses and meaningful OS. Courtney Jones, PhD, was selected to be an AACR 2023 NextGen Star and focuses on translational leukemia research. Dr. June has made “seminal contributions” to CAR T-cell therapy for blood cancers,